TNFRSF9 and systemic lupus erythematosus: As shown in Figure 1(a), the percentage of CD3+CD137+ T cells in SLE patients was significantly higher compared to HDs (median 5.32 (IQR 6.11) versus 3.3 (IQR 1.8), p = 0.001; Figure 1(a)).